Does the media prefer HQY or CLOV?

In the previous week, HealthEquity had 4 more articles in the media than Clover Health Investments. MarketBeat recorded 7 mentions for HealthEquity and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat HealthEquity's score of 1.04 indicating that Clover Health Investments is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ALHC or CLOV?

In the previous week, Alignment Healthcare had 12 more articles in the media than Clover Health Investments. MarketBeat recorded 15 mentions for Alignment Healthcare and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat Alignment Healthcare's score of 0.28 indicating that Clover Health Investments is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alignment Healthcare 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CLOV or UNH?

In the previous week, UnitedHealth Group had 41 more articles in the media than Clover Health Investments. MarketBeat recorded 44 mentions for UnitedHealth Group and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat UnitedHealth Group's score of 0.97 indicating that Clover Health Investments is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UnitedHealth Group 29 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor ELV or CLOV?

In the previous week, Elevance Health had 24 more articles in the media than Clover Health Investments. MarketBeat recorded 27 mentions for Elevance Health and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat Elevance Health's score of 1.27 indicating that Clover Health Investments is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 20 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HUM or CLOV?

In the previous week, Humana had 12 more articles in the media than Clover Health Investments. MarketBeat recorded 15 mentions for Humana and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat Humana's score of 1.11 indicating that Clover Health Investments is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 9 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Clover Health Investments (CLOV) Competitors

$4.82 +0.11 (+2.34%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$4.78 -0.04 (-0.75%)

As of 09/11/2026 07:59 PM Eastern

Compare

CLOV vs. HQY, ALHC, UNH, ELV, and HUM

Should you buy Clover Health Investments stock or one of its competitors? Clover Health Investments's main competitors and comparable companies include HealthEquity (HQY), Alignment Healthcare (ALHC), UnitedHealth Group (UNH), Elevance Health (ELV), and Humana (HUM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Clover Health Investments compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HealthEquity has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.36B	5.85	$215.20M	$2.77	34.75
Clover Health Investments	$2.48B	1.03	-$85.55M	-$0.05	N/A

HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market.

HealthEquity has a net margin of 17.36% compared to Clover Health Investments' net margin of -0.74%. HealthEquity's return on equity of 15.33% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Clover Health Investments	-0.74%	-4.20%	-2.28%

HealthEquity presently has a consensus price target of $111.87, indicating a potential upside of 16.21%. Clover Health Investments has a consensus price target of $4.75, indicating a potential downside of 1.45%. Given HealthEquity's stronger consensus rating and higher probable upside, research analysts plainly believe HealthEquity is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, HealthEquity had 4 more articles in the media than Clover Health Investments. MarketBeat recorded 7 mentions for HealthEquity and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat HealthEquity's score of 1.04 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthEquity beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Alignment Healthcare?

Alignment Healthcare (NASDAQ:ALHC) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

Alignment Healthcare has a net margin of 0.89% compared to Clover Health Investments' net margin of -0.74%. Alignment Healthcare's return on equity of 20.02% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
Clover Health Investments	-0.74%	-4.20%	-2.28%

86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Alignment Healthcare has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market.

Alignment Healthcare has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$4.58B	0.57	-$720K	$0.19	66.37
Clover Health Investments	$2.48B	1.03	-$85.55M	-$0.05	N/A

In the previous week, Alignment Healthcare had 12 more articles in the media than Clover Health Investments. MarketBeat recorded 15 mentions for Alignment Healthcare and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat Alignment Healthcare's score of 0.28 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alignment Healthcare	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alignment Healthcare currently has a consensus price target of $23.60, indicating a potential upside of 87.15%. Clover Health Investments has a consensus price target of $4.75, indicating a potential downside of 1.45%. Given Alignment Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Alignment Healthcare is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Alignment Healthcare beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to UnitedHealth Group?

Clover Health Investments (NASDAQ:CLOV) and UnitedHealth Group (NYSE:UNH) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Clover Health Investments has a beta of 2.47, meaning that its share price is 147% more volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

UnitedHealth Group has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$2.48B	1.03	-$85.55M	-$0.05	N/A
UnitedHealth Group	$447.57B	0.76	$12.06B	$15.54	24.38

UnitedHealth Group has a net margin of 3.14% compared to Clover Health Investments' net margin of -0.74%. UnitedHealth Group's return on equity of 16.53% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-0.74%	-4.20%	-2.28%
UnitedHealth Group	3.14%	16.53%	5.43%

In the previous week, UnitedHealth Group had 41 more articles in the media than Clover Health Investments. MarketBeat recorded 44 mentions for UnitedHealth Group and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat UnitedHealth Group's score of 0.97 indicating that Clover Health Investments is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UnitedHealth Group	29 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by insiders. Comparatively, 0.2% of UnitedHealth Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Clover Health Investments presently has a consensus target price of $4.75, suggesting a potential downside of 1.45%. UnitedHealth Group has a consensus target price of $456.56, suggesting a potential upside of 20.52%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts clearly believe UnitedHealth Group is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
UnitedHealth Group	0 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85

Summary

UnitedHealth Group beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Elevance Health?

Elevance Health (NYSE:ELV) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Elevance Health has a net margin of 2.47% compared to Clover Health Investments' net margin of -0.74%. Elevance Health's return on equity of 14.64% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.47%	14.64%	5.22%
Clover Health Investments	-0.74%	-4.20%	-2.28%

In the previous week, Elevance Health had 24 more articles in the media than Clover Health Investments. MarketBeat recorded 27 mentions for Elevance Health and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat Elevance Health's score of 1.27 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	20 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health presently has a consensus target price of $440.90, indicating a potential upside of 5.37%. Clover Health Investments has a consensus target price of $4.75, indicating a potential downside of 1.45%. Given Elevance Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Elevance Health is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Elevance Health has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, suggesting that its stock price is 147% more volatile than the broader market.

Elevance Health has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.46	$5.66B	$22.50	18.60
Clover Health Investments	$2.48B	1.03	-$85.55M	-$0.05	N/A

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Elevance Health beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Humana?

Humana (NYSE:HUM) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

In the previous week, Humana had 12 more articles in the media than Clover Health Investments. MarketBeat recorded 15 mentions for Humana and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.34 beat Humana's score of 1.11 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.4% of Humana shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Humana has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.38	$1.19B	$10.57	38.67
Clover Health Investments	$2.48B	1.03	-$85.55M	-$0.05	N/A

Humana currently has a consensus target price of $403.91, indicating a potential downside of 1.19%. Clover Health Investments has a consensus target price of $4.75, indicating a potential downside of 1.45%. Given Humana's stronger consensus rating and higher probable upside, equities research analysts clearly believe Humana is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Humana has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market.

Humana has a net margin of 0.88% compared to Clover Health Investments' net margin of -0.74%. Humana's return on equity of 11.20% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Clover Health Investments	-0.74%	-4.20%	-2.28%

Summary

Humana beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLOV vs. The Competition

Export

Metric	Clover Health Investments	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.50B	$9.87B	$7.15B	$12.71B
Dividend Yield	N/A	2.61%	2.56%	11.15%
P/E Ratio	-96.38	33.27	272.98	25.27
Price / Sales	1.03	5.51	646.20	90.55
Price / Cash	N/A	125.76	77.04	51.44
Price / Book	8.17	5.29	10.33	6.20
Net Income	-$85.55M	$313.25M	$3.49B	$358.27M
7 Day Performance	13.15%	-1.26%	-3.33%	-2.36%
1 Month Performance	6.17%	-0.98%	-0.42%	-2.77%
1 Year Performance	57.52%	15.13%	19.22%	7.64%

Clover Health Investments Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLOV Clover Health Investments	1.4597 of 5 stars	$4.82 +2.3%	$4.75 -1.5%	+53.5%	$2.50B	$2.48B	N/A	724	Analyst Forecast
HQY HealthEquity	4.2664 of 5 stars	$94.55 +2.0%	$111.87 +18.3%	+4.2%	$7.66B	$1.31B	34.13	2,814	Positive News
ALHC Alignment Healthcare	4.2523 of 5 stars	$12.76 -2.1%	$23.60 +85.0%	-22.9%	$2.70B	$3.95B	67.16	1,849	Trending News Insider Trade
UNH UnitedHealth Group	4.9579 of 5 stars	$387.69 -1.4%	$456.56 +17.8%	+7.0%	$352.81B	$447.57B	24.95	390,000	Trending News Options Volume
ELV Elevance Health	4.2143 of 5 stars	$416.58 +5.0%	$440.90 +5.8%	+33.1%	$86.08B	$199.13B	18.51	97,100	Positive News High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CLOV) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clover Health Investments (CLOV) Competitors

CLOV vs. HQY, ALHC, UNH, ELV, and HUM

How does Clover Health Investments compare to HealthEquity?

Summary

How does Clover Health Investments compare to Alignment Healthcare?

Summary

How does Clover Health Investments compare to UnitedHealth Group?

Summary

How does Clover Health Investments compare to Elevance Health?

Summary

How does Clover Health Investments compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLOV vs. The Competition

Clover Health Investments Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clover Health Investments (CLOV) Competitors

CLOV vs. HQY, ALHC, UNH, ELV, and HUM

How does Clover Health Investments compare to HealthEquity?

Do insiders & institutionals have more ownership in HQY or CLOV?

Which has stronger valuation & earnings, HQY or CLOV?

Which has more risk and volatility, HQY or CLOV?

Is HQY or CLOV more profitable?

Do analysts recommend HQY or CLOV?

Does the media prefer HQY or CLOV?

Summary

How does Clover Health Investments compare to Alignment Healthcare?

Is ALHC or CLOV more profitable?

Do insiders and institutionals believe in ALHC or CLOV?

Which has more risk & volatility, ALHC or CLOV?

Which has higher earnings & valuation, ALHC or CLOV?

Does the media favor ALHC or CLOV?

Do analysts recommend ALHC or CLOV?

Summary

How does Clover Health Investments compare to UnitedHealth Group?

Which has more risk & volatility, CLOV or UNH?

Which has better valuation and earnings, CLOV or UNH?

Is CLOV or UNH more profitable?

Does the media refer more to CLOV or UNH?

Do institutionals and insiders hold more shares of CLOV or UNH?

Do analysts rate CLOV or UNH?

Summary

How does Clover Health Investments compare to Elevance Health?

Is ELV or CLOV more profitable?

Does the media favor ELV or CLOV?

Do analysts rate ELV or CLOV?

Which has more volatility & risk, ELV or CLOV?

Which has stronger valuation and earnings, ELV or CLOV?

Do institutionals & insiders have more ownership in ELV or CLOV?

Summary

How does Clover Health Investments compare to Humana?

Does the media prefer HUM or CLOV?

Do insiders and institutionals have more ownership in HUM or CLOV?

Which has better valuation and earnings, HUM or CLOV?

Do analysts prefer HUM or CLOV?

Which has more risk and volatility, HUM or CLOV?

Is HUM or CLOV more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLOV vs. The Competition

Clover Health Investments Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools